Strain Data Sheet


Strain Information

BRC No.RBRC02339
TypeTransgene CongenicCartagena
SpeciesMus musculus
Strain nameB6.Cg-Tg(Tec-p210 BCR/ABL1)1Homy
Former Common namep210<bcr/abl> Tg
H-2 Haplotype
ES Cell line
Background strainC57BL/6NCrlCrlj
Appearanceblack [a/a B/B C/C]
Strain developmentDeveloped by Drs. Honda and Hirai, University of Tokyo in 1998.
Strain descriptionThis transgenic strain expresses the p210 BCR/ABL1 gene. Tg mice show marked granulocyte hyperplasia and develop myeloproliferative disorders closely resembling human chronic myelogenous leukemia.
Colony maintenanceBackcross to C57BL/6 (Hemizygote x C57BL/6NCrlCrlj)
ReferencesOncogene. 2008 May 29;27(24):3465-74. 18193087
Cancer Sci. 2009 Jul;100(7):1219-26. 19432895
Blood, 91, 2067-2075 (1998). 9490692
Blood. 2009 May 7;113(19):4702-10. 19234145

Health Report

Examination Date / Room / Rack


Gene info
Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
BCR/ABL1p210 bcr/abl1 (human)UNBCR/ABL1mouse Tec

Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter
poly ASV40 polyA siganlUNpoly A

Ordering Information

Donor DNAmouse Tec genomic DNA, human p210<bcr/abl> cDNA, SV40 virus poly A signal DNA
Research applicationCancer Research
Immunology and Inflammation Research
Specific Term and ConditionsPrior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form.
DepositorHiroaki Honda (Tokyo Women's Medical University)
Strain Statusan icon for Frozen embryosFrozen embryos
an icon for Frozen spermFrozen sperm
Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
Cryopreserved sperm (within 1 month)
Additional Info.Necessary documents for ordering:
  1. Approval form (Japanese / English)
  2. Order form (Japanese / English)
  3. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
  4. Acceptance of responsibility for living modified organism (Japanese / English)
Lab HP (Japanese)
Genotyping protocol -PCR-

BRC mice in Publications

Sánchez-Sánchez B, Gutiérrez-Herrero S, López-Ruano G, Prieto-Bermejo R, Romo-González M, Llanillo M, Pandiella A, Guerrero C, Miguel JF, Sánchez-Guijo F, Del Cañizo C, Hernández-Hernández A.
NADPH oxidases as therapeutic targets in chronic myelogenous leukemia.
Clin Cancer Res 20(15) 4014-25(2014) 24833663